Drug Profile
Research programme: hepatitis B vaccine - Mologen/Synvolux
Alternative Names: MGN 1333Latest Information Update: 29 Jun 2016
Price :
$50
*
At a glance
- Originator Mologen; Synvolux Therapeutics
- Developer Mologen
- Class Viral hepatitis vaccines
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Hepatitis B